Here’s what the science says.
The Chosun Ilbo on MSN
Single-injection gene therapies target obesity cure
Recently, GLP-1 (glucagon-like peptide-1) class obesity treatments such as ‘Wegovy’ and ‘Mounjaro’ have gained immense ...
MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.
GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points ...
Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...
Ascletis Pharma Inc. has selected ASC-37 injection, a next-generation, once-monthly, subcutaneously administered glucagon-like peptide-1 receptor (GLP-1R)/gastric inhibitory polypeptide receptor (GIPR ...
Here's what San Antonio doctors say about the widespread use of GLP-1 medications for obesity, diabetes and other conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results